# Prevalence and Treatment of Anemia in Rehabilitation Patients

> **NCT00511901** · PHASE4 · TERMINATED · sponsor: **University of Medicine and Dentistry of New Jersey** · enrollment: 22 (actual)

## Conditions studied

- Anemia

## Interventions

- **DRUG:** placebo
- **DRUG:** epoetin alpha
- **DRUG:** Niferex

## Key facts

- **NCT ID:** NCT00511901
- **Lead sponsor:** University of Medicine and Dentistry of New Jersey
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2005-11
- **Primary completion:** 2008-05
- **Final completion:** 2008-05
- **Target enrollment:** 22 (ACTUAL)
- **Why stopped:** Study enrollment was suspended in response to an FDA alert regarding the study drug. The study was subsequently terminated
- **Last updated:** 2014-01-31

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00511901

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00511901, "Prevalence and Treatment of Anemia in Rehabilitation Patients". Retrieved via AI Analytics 2026-08-24 from https://api.ai-analytics.org/clinical/NCT00511901. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*